Scott Zamost on Muck Rack

Scott Zamost

Verified
  • Senior Investigative Producer, CNBC
New York
As seen in: CNBC, LinkedIn, CNN, CNN Business, CNN en Español, CNN International, MSN, MSN Canada, Yahoo News, Aol, NBC News and
CNBC Senior Investigative Producer. Previous: CNN, CBS News, NBC 6 Miami and WPLG-TV. World traveler. Mentor and conference speaker. Scott.zamost@cnbc.com

Get in touch with Scott

Contact Scott, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Scott Zamost’s Biography

Read Full Bio →

Scott Zamost is senior investigative producer at CNN where he has worked since 2008.

He is a two-time winner of the Investigative Reporters and Editors (IRE) Award and a frequent speaker at IRE and international investigative reporting conferences.

His investigations have ranged from government fraud to war crimes in Iraq.

Among his stories is "Rehab Racket," a groundbreaking investigation into massive fraud in taxpayer-funded drug rehab. The three-part series, a yearlong collaboration with The…

Articles

Eli Lilly accuses church bishops, businessmen of fraud in Trulicity drug rebate scheme

|
By Scott Zamost Verified
| CNBC Verified
The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly says it has uncovered a long-running scheme to steal more than $200 million in rebates from its diabetes medication, Trulicity, accusing several bishops at a major Pentecostal church of fraud. The company filed a 66-page civil lawsuit Tuesday in U.S. District Court in Miami.
Open in Who Shared Issue with article?

FDA declines to issue specific guidance on health programs' foreign drug imports Original

|
By Scott Zamost Verified, Melissa Lee Verified, Paige Tortorelli Verified
| CNBC Verified
The headquarters of the U.S. Food and Drug Administration in Silver Spring, Maryland, Nov. 4, 2009. Jason Reed | Reuters The Food and Drug Administration in recent weeks said it would decline to clarify laws that ban the foreign importation of prescription medicines, despite growing evidence of the overseas schemes.
Open in Who Shared View Duplicates (3) Issue with article?

Novartis, Genentech file suit alleging illegal importation of prescription drug Original

|
By Melissa Lee Verified, Paige Tortorelli Verified, Scott Zamost Verified
| CNBC Verified
A sign of Swiss pharmaceutical giant Novartis is seen on the top of a building at Novartis Campus in Basel on Sept. 9, 2025. Fabrice Coffrini | AFP | Getty Images Novartis, one of the world's largest pharmaceutical companies, and Genentech, a major biotech firm, say they've uncovered a "dangerous scheme" to import their allergy medication from Canada into the U.S. in violation of U.S. Food and Drug Administration regulations.
Open in Who Shared View Duplicates (2) Issue with article?
See all 458 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified